PRN: World Therapeutic Drug Monitoring Research Study 2017: Technologies, Markets, and Companies Projections 2016-2026

06/lug/2017 18:30:11 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

World Therapeutic Drug Monitoring Research Study 2017: Technologies, Markets, and Companies Projections 2016-2026


DUBLIN, July 6, 2017 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering.


This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome.

TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described.

A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2016 to 2026 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2016 to 2026 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed.

Benefits of this report

- Up-to-date one-stop information on therapeutic drug monitoring- Description of 27 companies involved with their collaborations in this area- Market analysis 2016-2026

- Market values in major regions

- Strategies for developing markets for therapeutic drug monitoring

- A selected bibliography of 190 publications

- Text is supplemented by 18 tables and 6 figures

Key Topics Covered:

Executive Summary

1. Introduction

2. Technologies for TDM

3. Drug Monitoring Instruments

4. Applications of TDM

5. Drugs Requiring Monitoring

6. Monitoring of Biological Therapies

7. Monitoring of Drug Abuse

8. Markets for TDM

9. Companies

10. References

Companies Mentioned

- Abbott
- Agilent
- Alfa Wassermann
- AMS Diagnostics
- Awareness Technology
- Beckman Coulter
- Binding Site
- bioMerieux
- Carolina
- Chromsystems
- Cobas®
- Grifols
- Indiko
- Medica
- Nova Biomedical
- Ortho Clinical Diagnostics
- Randox
- Roche
- Siemens
- Thermo Scientific
- Tosoh

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl